The results of this research showed that PLCγ1 silencing in IDH-wildtype LGG cell lines dramatically affects their progression, migration, and invasiveness and that the PLC-targeted drug significantly suppresses the tumor growth of both IDH-wildtype in vitro and mouse models [41]. This evidence concerns the gene HSPG2 and neoplasm.